Download this PDF file
Crossref Citations
1. Genetic Aspects of Mycobacterium Tuberculosis Resistance to New Anti-Tuberculosis Drugs
A. V. Kukurika, E. I. Veselova, A. B. Peregudova
Tuberculosis and Lung Diseases vol: 101 issue: 4 first page: 87 year: 2023
doi: 10.58838/2075-1230-2023-101-4-87-93
2.
Emergence of Canonical and Noncanonical Genomic Variants following
In Vitro
Exposure of Clinical Mycobacterium tuberculosis Strains to Bedaquiline or Clofazimine
N. Ismail, A. Dippenaar, R. M. Warren, R. P. H. Peters, S. V. Omar
Antimicrobial Agents and Chemotherapy vol: 67 issue: 4 year: 2023
doi: 10.1128/aac.01368-22
3.
In Vitro
Study of Stepwise Acquisition of
rv0678
and
atpE
Mutations Conferring Bedaquiline Resistance
Nabila Ismail, Nazir A. Ismail, Shaheed V. Omar, Remco P. H. Peters
Antimicrobial Agents and Chemotherapy vol: 63 issue: 8 year: 2019
doi: 10.1128/AAC.00292-19
4.
Bedaquiline Drug Resistance Emergence Assessment in Multidrug-Resistant Tuberculosis (MDR-TB): a 5-Year Prospective
In Vitro
Surveillance Study of Bedaquiline and Other Second-Line Drug Susceptibility Testing in MDR-TB Isolates
Koné Kaniga, Rumina Hasan, Ruwen Jou, Edita Vasiliauskienė, Charoen Chuchottaworn, Nazir Ismail, Beverly Metchock, Skaidrius Miliauskas, Nguyen Viet Nhung, Camilla Rodrigues, Soyoun Shin, Hulya Simsek, Saijai Smithtikarn, Anh Le Thi Ngoc, Jirakan Boonyasopun, Mubin Kazi, Seungmo Kim, Phalin Kamolwat, Greta Musteikiene, Catherine Ann Sacopon, Sabira Tahseen, Laima Vasiliauskaitė, Mei-Hua Wu, Shaheed Vally Omar, Christine Y. Turenne
Journal of Clinical Microbiology vol: 60 issue: 1 year: 2022
doi: 10.1128/JCM.02919-20
